Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.172
+0.032 (1.02%)
Jan 21, 2025, 4:00 PM EST - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $113.99 million as of January 21, 2025. Its market cap has decreased by -4.77% in one year.
Market Cap
113.99M
Enterprise Value
104.47M
1-Year Change
-4.77%
Ranking
Category
Stock Price
3.17
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $113.99M, an increase of 85.00%. That is a compound annual growth rate of 17.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 115.43M | 3.38% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |